Outcomes of Per Oral Endoscopic Pyloromyotomy in the United States

Parit Mekaroonkamol; Sunil Dacha; Vaishali Patel; Baiwen Li; Hui Luo; Shanshan Shen; Huimin Chen; Qiang Cai

doi:10.1016/j.giec.2018.08.009

Outcomes of Per Oral Endoscopic Pyloromyotomy in the United States

Gastrointest Endosc Clin N Am. 2019 Jan;29(1):151-160. doi: 10.1016/j.giec.2018.08.009. Epub 2018 Sep 22.

Authors

Parit Mekaroonkamol¹, Sunil Dacha¹, Vaishali Patel¹, Baiwen Li¹, Hui Luo¹, Shanshan Shen¹, Huimin Chen¹, Qiang Cai²

Affiliations

¹ Division of Digestive Diseases, Emory University School of Medicine, 615 Michael Street, Suite 201, Atlanta, GA 30322, USA.
² Division of Digestive Diseases, Emory University School of Medicine, 615 Michael Street, Suite 201, Atlanta, GA 30322, USA. Electronic address: qcai@emory.edu.

PMID: 30396525
DOI: 10.1016/j.giec.2018.08.009

Abstract

Per oral endoscopic pyloromyotomy (POP) has emerged as an endoscopic intervention for refractory gastroparesis. Early experience in the United States showed exciting clinical response rate, reduced gastroparesis symptoms, improved quality of life, and decreased gastric-emptying time during midterm follow-up up to 18 months. One recent study also showed that the number of patient emergency room visits and hospitalizations decreased significantly after POP. The procedure is technically feasible and safe. As more data become available, it is important to identify patients who would benefit most from this novel procedure.

Keywords: Gastroparesis; Outcomes; POP; Pyloromyotomy.

Publication types

Review

MeSH terms

Gastroparesis / surgery*
Gastroscopy
Humans
Pyloromyotomy*
Pylorus / surgery*
Treatment Outcome
United States